Insights from Biosimilars
to AI Model Validation

Fox-based Radical Protein Footprinting (RPF) studies provide impactful, actionable results across the drug discovery and development pipeline. The growing application of Fox Technology in biopharmaceutical research empowers our customers to gain valuable insights into diverse areas of structural biology.

Biotherapeutics & Monoclonal Antibodies (mAbs)

Improve the efficacy, safety, and manufacturability of biotherapeutic and mAb products.

  • Interaction & aggregation analysis
  • Biosimilarity assessment & stability optimization
  • Formulation & delivery

Small Molecule Drug Discovery

Promote promising leads while eliminating those that inappropriately bind or elicit an undesired target response.

  • Target engagement & response
  • Lead optimization & structure-activity relationships

Artificial Intelligence & Computational Biology

Enhance the probability of drug discovery success by quickly confirming or refuting AI hypotheses.

  • Identify potential aggregation-prone regions and stability issues
  • Test hypotheses for rapid target screening
  • Validate targets and pathways
  • Supplement AI predictions by revealing mechanistic details

Request a custom webinar for your lab.